AcelRx Pharmaceuticals logo
AcelRx Pharmaceuticals ACRX
€ 0.82 7.5%

Quartalsbericht 2024-Q3
hinzugefügt 13.11.2024

report update icon

AcelRx Pharmaceuticals Kennzahlen 2011-2025 | ACRX

Kennzahlen Jährlich AcelRx Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.7 0.1 -0.1 -4.6 -2.6 -3.0 -1.8 -2.7 -6.6 -8.7 -19.9 -3.4 -2.3

P/S

18.8 2.7 1.0 34.6 59.5 66.8 11.4 6.8 8.3 55.8 15.8 47.3 43.5

EPS

-1.3 5.7 -5.9 -0.5 -0.7 -0.8 -1.1 -0.9 -0.6 -0.8 -0.6 -1.5 -1.2

EV (Enterprise Value)

12.8 M 15.1 M 109 M 282 M 254 M 172 M 151 M 143 M 147 M 271 M 414 M 96 M 62.2 M

EBITDA per Share

-1.16 -3.2 -5.67 -0.459 -0.663 -0.602 -0.788 -0.66 -0.389 -0.847 -0.153 -1.32 -1.09

EV/EBITDA

-3.0 -4.7 -2.8 -1.9 -1.6 -2.0 -4.2 -7.0 -64.5 -2.8 -3.1

PEG

-0.0 0.0 -0.0 -0.16 -0.15 -0.12 0.11 0.04 -0.23 0.29 -0.33 0.11 -0.02

P/B

0.9 0.2 -0.1 -3.4 -3.3 33.8 -2.5 -22.1 4.8 6.2 6.4 3.3 2.7

P/CF

-0.7 -0.2 -0.1 -4.6 -2.5 -4.8 -2.8 -3.6 -7.5 -7.3 -123.4 -4.5 -2.7

ROE %

-130.43 218.92 97.79 72.43 128.54 -1108.61 141.08 808.64 -73.68 -71.49 -32.02 -98.57 -115.07

ROA %

-90.20 100.56 -45.06 -60.91 -58.28 -39.12 -68.18 -43.16 -19.09 -38.58 -21.29 -51.71 -49.22

ROCE %

-119.74 -115.98 100.20 -84.18 -69.72 -34.15 -62.50 -35.59 -16.69 -51.78 -6.46 -59.20 -58.66

Current Ratio

3.2 1.8 0.7 2.7 5.3 6.8 4.6 8.7 9.3 5.6 15.2 4.3 4.9

DSO

- 16.5 51.5 42.8 82.9 68.0 70.0 122.7 62.3 - - - -

DIO

- - 133.1 98.4 176.7 78.4 32.7 63.8 96.1 - - - -

DPO

- - 236.2 165.6 92.2 190.0 48.8 46.2 321.9 - - - -

Betriebszyklus

- 16.5 184.6 141.2 259.6 146.4 102.7 186.5 158.4 - - - -

Finanzkreislauf

- 16.5 -51.6 -24.4 167.4 -43.6 54.0 140.3 -163.5 - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202320232022202220212021202020202019201920182018201720172016201620152015201420142013201320122012201120111000 1000 500 500 0 0 -500 -500 -1000 -1000 -1500 -1500
Download SVG
Download PNG
Download CSV

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich AcelRx Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.13 -0.15 -0.16 - -0.08 -0.4 -0.75 - -0.94 8.58 -1.19 - -1.4 -0.08 -0.08 - -0.1 -0.08 -0.2 -0.18 -0.16 -0.16 -0.17 -0.18 -0.21 -0.2 -0.23 -0.2 -0.28 -0.29 -0.34 -0.21 -0.25 -0.24 -0.24 -0.24 0.11 -0.2 -0.23 -320 20 -240 -220 0.41 -0.26 -0.47 -0.34 -0.41 -0.38 -0.35 -0.36 -0.33 -0.3 -0.25 -0.3

EBITDA per Share

- - - - - - -0.47 - -0.72 -1.73 -0.03 - -1.19 -0.08 -0.08 - -0.09 -0.07 -0.19 - -0.16 -0.16 -0.15 - -0.15 -0.13 -0.16 - -0.16 -0.2 -0.26 - -0.14 -0.16 -0.18 - 0.19 -0.16 -0.25 - -0.11 0.01 - - 0.01 0.01 - - 0.02 0.02 0.01 - 0.02 0.01 0.01

ROE %

-96.46 -69.09 -80.98 -106.60 -131.40 -148.78 106.38 211.08 230.54 274.80 88.97 79.63 95.65 92.20 76.68 56.43 91.26 105.98 124.09 128.54 -201.55 -525.21 -803.03 -1108.61 -786.26 -457.69 -174.07 141.08 295.42 473.42 645.48 808.64 595.38 397.04 162.35 -73.68 -71.45 -85.32 -81.12 -71.49 -17.58 -34.04 -35.22 -32.02 -87.40 -97.73 -95.14 -98.57 -103.97 -111.59 -117.60 -115.07 -32.98 -27.27 -18.34

ROA %

-50.93 -40.81 -50.07 -61.50 -75.47 -83.61 66.93 99.86 88.27 90.65 -47.61 -34.22 -47.69 -49.57 -47.16 -47.46 -63.24 -63.71 -67.33 -58.28 -52.91 -49.31 -44.47 -39.12 -41.78 -48.67 -57.21 -68.18 -64.77 -58.95 -52.76 -43.16 -41.73 -26.36 -22.23 -19.09 -26.83 -30.02 -35.29 -38.59 -6.45 -17.21 -20.83 -21.29 -53.75 -57.06 -52.36 -51.71 -51.01 -51.81 -52.33 -49.22 -14.11 -11.66 -7.85

ROCE %

- - -37.41 -74.82 -99.18 -86.13 -127.08 -52.42 -32.35 12.08 80.86 81.37 97.58 93.72 78.15 56.90 89.57 106.04 126.04 94.68 -124.65 -376.66 -577.10 -581.94 -557.67 -314.07 -118.66 84.57 234.00 359.15 487.86 465.04 486.49 358.52 178.06 -37.50 -48.37 -80.69 -56.16 -10.86 -10.86 - - - - - - - - - - - - - -

Current Ratio

1.9 2.0 2.3 3.2 4.7 2.4 2.2 1.9 2.3 2.4 0.7 0.7 0.6 0.7 0.8 0.5 0.5 0.5 0.5 0.7 0.7 0.7 0.7 1.0 1.0 1.0 1.0 0.7 0.7 0.7 0.7 0.9 0.9 0.9 0.9 1.4 1.4 1.4 1.4 2.2 2.2 2.2 2.2 3.0 3.0 3.0 3.0 2.1 2.1 2.1 2.1 1.8 1.8 1.8 1.8

DSO

- - - - - - - - 78.8 43.9 35.5 - 6.3 78.5 115.5 - 42.4 19.8 126.1 83.0 64.8 41.9 82.8 7.3 11.9 5.5 210.4 189.0 94.1 52.6 108.1 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

DIO

- - - - - - - - 142.3 101.3 125.5 - 303.4 122.0 133.6 - 80.2 108.3 148.6 - 140.0 166.1 153.9 - 89.1 104.0 74.1 - 43.0 24.6 34.4 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - 353.1 266.4 281.4 - 433.3 227.1 262.0 - 134.9 182.3 134.6 - 73.1 86.7 140.6 - 215.9 252.2 143.1 - 64.0 36.7 33.0 - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - 221.2 145.2 161.0 - 309.7 200.5 249.0 - 122.5 128.1 274.7 83.0 204.8 208.0 236.7 7.3 100.9 109.5 284.6 189.0 137.1 77.2 142.5 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - -131.9 -121.2 -120.5 - -123.6 -26.5 -13.0 - -12.4 -54.2 140.1 83.0 131.8 121.3 96.1 7.3 -115.0 -142.7 141.5 189.0 73.0 40.5 109.5 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung